RUSSO, Emilio
 Distribuzione geografica
Continente #
NA - Nord America 5.999
AS - Asia 4.231
EU - Europa 2.589
SA - Sud America 1.082
AF - Africa 103
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 27
Totale 14.085
Nazione #
US - Stati Uniti d'America 5.631
SG - Singapore 1.871
IT - Italia 1.074
BR - Brasile 849
CN - Cina 848
IN - India 490
VN - Vietnam 467
DE - Germania 366
GB - Regno Unito 313
CA - Canada 300
SE - Svezia 240
FI - Finlandia 177
HK - Hong Kong 117
AR - Argentina 83
ID - Indonesia 65
RU - Federazione Russa 60
FR - Francia 52
NL - Olanda 52
AE - Emirati Arabi Uniti 51
AU - Australia 51
TR - Turchia 48
MX - Messico 45
EC - Ecuador 43
CO - Colombia 41
JP - Giappone 36
RO - Romania 36
ZA - Sudafrica 36
BD - Bangladesh 33
ES - Italia 30
PL - Polonia 29
PK - Pakistan 27
CL - Cile 26
EG - Egitto 25
UA - Ucraina 25
EU - Europa 22
IL - Israele 19
EE - Estonia 18
IQ - Iraq 17
IR - Iran 16
MY - Malesia 16
SA - Arabia Saudita 16
GR - Grecia 15
TW - Taiwan 15
KR - Corea 14
CH - Svizzera 13
CZ - Repubblica Ceca 13
PH - Filippine 13
PY - Paraguay 12
AT - Austria 11
PE - Perù 10
IE - Irlanda 9
PT - Portogallo 8
VE - Venezuela 8
BE - Belgio 7
DO - Repubblica Dominicana 7
MT - Malta 7
UZ - Uzbekistan 7
KE - Kenya 6
UY - Uruguay 6
LT - Lituania 5
MD - Moldavia 5
NG - Nigeria 5
NP - Nepal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
AZ - Azerbaigian 4
BO - Bolivia 4
HR - Croazia 4
KZ - Kazakistan 4
MA - Marocco 4
NO - Norvegia 4
SC - Seychelles 4
TT - Trinidad e Tobago 4
AF - Afghanistan, Repubblica islamica di 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
ET - Etiopia 3
JO - Giordania 3
OM - Oman 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
UG - Uganda 3
AO - Angola 2
BN - Brunei Darussalam 2
CY - Cipro 2
DZ - Algeria 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SO - Somalia 2
TH - Thailandia 2
BS - Bahamas 1
Totale 14.066
Città #
Chandler 981
Singapore 759
Dallas 524
Santa Clara 338
Bengaluru 322
Hefei 310
Milan 309
Munich 277
Princeton 275
Lawrence 268
Ashburn 214
Ottawa 190
London 183
Ho Chi Minh City 171
Wilmington 154
Catanzaro 153
Chicago 149
Hong Kong 109
Beijing 106
Des Moines 100
Hanoi 96
Turku 94
Boardman 90
São Paulo 88
Helsinki 74
New York 74
Los Angeles 60
Redwood City 53
Rome 41
Brooklyn 40
Guangzhou 33
Shanghai 33
Boston 30
The Dalles 28
Haiphong 27
Montreal 26
Rio de Janeiro 25
Tokyo 25
Columbus 24
Warsaw 24
Norwalk 23
Toronto 23
Council Bluffs 22
Curitiba 22
Atlanta 21
Redmond 21
Melbourne 20
Pune 20
Bogotá 19
Naples 19
Brasília 18
Istanbul 18
Shenzhen 18
Florence 17
Amsterdam 16
Guayaquil 16
Johannesburg 16
Padova 16
Thái Bình 16
Da Nang 15
Jakarta 15
Timisoara 15
Chennai 14
Hyderabad 14
Porto Alegre 14
San Francisco 14
San Nicola Manfredi 14
Stockholm 14
Falls Church 13
Messina 13
Phoenix 13
Seattle 12
Bari 11
Buenos Aires 11
Campinas 11
Hải Dương 11
Mexico City 11
Mumbai 11
Olomouc 11
Sydney 11
West Jordan 11
Ankara 10
Guarulhos 10
Nanjing 10
Palermo 10
Philadelphia 10
Santa Maria 10
Augusta 9
Belo Horizonte 9
Biên Hòa 9
Denver 9
Hanover 9
Latina 9
Quito 9
Salvador 9
Vallefiorita 9
Ann Arbor 8
Assago 8
Boydton 8
Cairo 8
Totale 7.690
Nome #
Adherence to therapy and adverse drug reactions: is there a link? 269
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 235
A Comprehensive Safety Evaluation of Trabectedin and Drug-Drug Interactions of Trabectedin-Based Combinations 149
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 149
Genetics of reflex seizures and epilepsies in humans and animals 143
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 120
Role of anatomical variations in chronic non polipoid rhinosinusitis 116
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 100
High Prevalence of Achilles Tendon Enthesopathic Changes in Patients with Type 2 Diabetes Without Peripheral Neuropathy 99
Uno strano caso di deterioramento cognitivo: quando le interazioni farmaco-alimenti diventano fondamentali. 98
Efficacy and safety of bevacizumab in glioblastomas 96
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 89
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 88
Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis An Observational Study 85
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 85
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 85
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 83
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 81
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 76
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 74
A review on antiepileptic drugs-dependent fatigue: Pathophysiological mechanisms and incidence 73
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention 71
Neuroactive steroids and GABA(A) receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy 71
Melaena following use of the cholinesterase inhibitor rivastigmine 70
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 70
New evidence for a critical role of elastin in calcification of native heart valves: immunohistochemical and ultrastructural study with literature review 70
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 69
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 69
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability 69
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome 69
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 67
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 67
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 67
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 67
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 67
Apomorphine-induced neurodegeneration in Mongolian gerbil hippocampus 66
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 66
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 66
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report 65
Classical differentiation protocols upregulate the expression of the axon guidance genes PLXNA2 and SEMA3C in SH-SY5Y neuroblastoma cells 65
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 64
Huperizine A Receptors Cortico-Hippocampal Functional Connectivity after Bilateral AMPA Lesion of the Nucleus Basalis of Meinert 64
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 64
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 63
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 63
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 63
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 62
Amino acid levels in some lethargic mouse brain areas before and after pentylenetetrazole kindling 62
Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes 62
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 62
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability 62
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 60
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 60
Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy 60
Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program 60
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 59
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 59
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 59
Adverse drug reactions related to drug administration in hospitalized patients. 59
Anti TNF.alpha biologic agents and insulin resistence in rheumatoid arthritis: A systematic review and Meta-analysis. Journal of Biological Regulators & Homeostatic Agents 59
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 59
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 59
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 58
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 58
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 58
Methodological issues associated with clinical trials in epilepsy 58
Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice 57
Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy 57
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 56
Pharmacokinetic considerations about antiseizure medications in the elderly 56
Pharmacokinetic drug interactions between antiseizure medications and drugs for comorbid diseases in children with epilepsy 56
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 55
Alpha-lactoalbumin, a whey protein rich in tryptophan, is effective in rodent models of seizures and epileptogenesis 55
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis 55
Huperizine A reduces neuronal loss and enhances brain expression of nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis 55
Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice 55
Analgesic and Anti-Inflammatory Effects of Perampanel in Acute and Chronic Pain Models in Mice: Interaction With the Cannabinergic System 55
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 55
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 54
Status epilepticus in pregnancy: a literature review and a protocol proposal 54
Renal denervation for resistant hypertension 54
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy 54
Bioinspired Electric Stimulation: Comparison of ECoG Spectrum in the Main Auditory Structures 54
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 54
A Volumetric Absorptive Microsampling Technique to Monitor Cannabidiol Levels in Epilepsy Patients 54
Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: Implications for inclusion and safety in the educational system 54
Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series. 54
Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease 54
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis 53
Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents 53
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior 53
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 53
The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes 52
Classical and non-classical proangiogenic factors as a target of antiangiogenic therapy in tumor microenvironment 52
Abatacept in psoriatic arthritis: Case report and short review. 52
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation  52
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 51
The safety of clozapine in the elderly 51
Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis 51
High prevalence of Achilles tendon enthesopathic changes in type 2 diabetes patients without peripheral neuropathy 51
Totale 7.091
Categoria #
all - tutte 142.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021459 0 0 0 0 0 203 60 21 77 46 43 9
2021/2022943 19 14 20 229 39 32 30 180 113 91 148 28
2022/20232.580 581 211 90 234 241 224 18 183 395 165 176 62
2023/20241.410 204 175 139 108 102 256 82 53 24 78 53 136
2024/20253.881 532 196 186 151 269 488 230 155 451 185 430 608
2025/20264.634 470 835 1.027 1.340 928 34 0 0 0 0 0 0
Totale 14.452